Saxagliptin but not sitagliptin inhibits CaMKII and PKC via DPP9 inhibition in cardiomyocytes
Published endocrinology research indicates that growth hormone production gradually declines with age in adults
For the study population with obesity, a separate analysis was performed in patients with T2D and patients without T2D
They are different expressions of the same biological reality: the body's ability to heal, protect, and renew itself declines across the decades in ways that accelerate disease and compress the years of genuine vitality
Ozempic, which has a lower dose of 0.5-2 semaglutide, is FDA-approved for diabetes control, while higher-dose semaglutide, Wegovy, is approved for weight loss
Small adjustments can kickstart progress